Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 8/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 12/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1453481 | 0.89 | CYP1A2 (0.57) | FFAR4FFAR1NPSR1ALDH1A1 | |
| SCHEMBL28106880 | 0.86 | IAPP (0.53) | FFAR4FFAR1 | |
| SCHEMBL11218783 | 0.85 | THRA (0.57) | FFAR4FFAR1NPSR1KEAP1 | |
| SCHEMBL18161715 | 0.85 | FFAR1 (0.53) | FFAR4FFAR1NPSR1KEAP1 | |
| SCHEMBL4632516 | 0.84 | ALDH1A1 (0.53) | FFAR4FFAR1ALDH1A1 | |
| Phenyl Propionic Acid SCHEMBL28555657 | 0.83 | FFAR4 (0.58) | FFAR4FFAR1KEAP1 | |
| SCHEMBL24893771 | 0.83 | FFAR1 (0.59) | FFAR4FFAR1NPSR1KEAP1 | |
| SCHEMBL16899346 | 0.83 | FFAR4 (0.54) | FFAR4FFAR1NPSR1KEAP1 | |
| SCHEMBL14110345 | 0.83 | NPSR1 (0.53) | FFAR4FFAR1NPSR1KEAP1 | |
| SCHEMBL14430305 | 0.83 | FFAR4 (0.54) | FFAR4FFAR1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11253596-B2 | Phenylalkylcarboxylic acid delivery agents | NOVO NORDISK NORTH AMERICA OPERATIONS A/S (DK) | 2022-02-22 | — | — | US | disclosed |
| US-20200405863-A1 | PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS | NOVO NORDISK A/S (DK) | 2020-12-31 | — | — | US | disclosed |
| US-10456472-B2 | Phenylalkylcarboxylic acid delivery agents | EMISPHERE TECHNOLOGIES, INC. (US) | 2019-10-29 | — | — | US | disclosed |
| US-9938204-B2 | Intermolecular C-H silylation of unactivated arenes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-04-10 | — | — | US | disclosed |
| EP-2114145-B1 | PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS | EMISPHERE TECH INC (US) | 2017-11-01 | — | — | EP | disclosed |
| US-20170217997-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | ORMCO CORPORATION | 2017-08-03 | — | — | US | disclosed |
| US-20160375135-A1 | PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2016-12-29 | — | — | US | disclosed |
| US-20160200639-A1 | INTERMOLECULAR C-H SILYLATION OF UNACTIVATED ARENES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-07-14 | — | — | US | disclosed |
| US-9365504-B2 | Salts of kukoamine B, preparation method and use thereof | THE FIRST AFFILIATED HOSPITAL, THIRD MILITARY UNIVERSITY, PLA (CN) | 2016-06-14 | — | — | US | disclosed |
| US-20130289112-A1 | SALTS OF KUKOAMINE B, PREPARATION METHOD AND USE THEREOF | TIANJIN CHASESUN PHARMACEUTICAL CO., LTD (CN) | 2013-10-31 | — | — | US | disclosed |
| US-6479424-B1 | FOR PRODUCING OLEFIN POLYMERS AND ESPECIALLY ELASTOMERIC PROPYLENE POLYMERS | BP CORPORATION NORTH AMERICA INC. | 2002-11-12 | — | — | US | disclosed |
| EP-1157047-A1 | LIGANDS AND CATALYSTS FOR PRODUCING ELASTOMERIC PROPYLENE POLYMERS | BP Corporation North America Inc. (US) | 2001-11-28 | — | — | EP | disclosed |
| WO-2000035975-A1 | LIGANDS AND CATALYSTS FOR PRODUCING ELASTOMERIC PROPYLENE POLYMERS | BP CORPORATION NORTH AMERICA INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-0721939-B1 | N-arylalkylphenylacetamide derivatives | KOREA RES INST CHEM TECH (KR) | 1998-04-15 | — | — | EP | disclosed |
| EP-0525360-B1 | Novel phenylacetamide derivatives and processes for the preparation thereof | KOREA RES INST CHEM TECH (KR) | 1998-03-25 | — | — | EP | disclosed |
| US-5670546-A | ANALGESICS, ANTIINFLAMMATORY AGENTS, RELATED TO CAPSAICIN BUT WITHOUT UNDESIRABLE SIDE EFFECTS | KOREAN RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1997-09-23 | — | — | US | disclosed |
| EP-0721939-A1 | N-arylalkylphenylacetamide derivatives | Korea Research Institute of Chemical Technology (KR) | 1996-07-17 | — | — | EP | disclosed |
| US-5242944-A | Analgesics or antiinflammatory agents | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1993-09-07 | — | — | US | disclosed |
| EP-0525360-A2 | Novel phenylacetamide derivatives and processes for the preparation thereof | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1993-02-03 | — | — | EP | disclosed |
| US-4026896-A | ANTIALLERGENS | KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (KISSEI PHARMACEUTICAL CO. LTD.) (JA) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200639-A1 | INTERMOLECULAR C-H SILYLATION OF UNACTIVATED ARENES | CCNH, CTTN, CCRL2 | FFAR4 2766/4885FFAR1 3159/4885NPSR1 2527/4885 |
| US-20200405863-A1 | PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS | PGF, LIPA, PDGFA | FFAR4 697/4885FFAR1 713/4885NPSR1 1464/4885 |
| US-20170217997-A1 | PHOTO-CLEAVABLE PRIMER COMPOSITIONS AND METHODS OF USE | SP1, GPER1, ESR1 | FFAR4 3270/4885FFAR1 2377/4885NPSR1 1766/4885 |
| US-10456472-B2 | Phenylalkylcarboxylic acid delivery agents | PGF, LIPA, PDGFA | FFAR4 697/4885FFAR1 713/4885NPSR1 1464/4885 |
| US-11253596-B2 | Phenylalkylcarboxylic acid delivery agents | PGF, LIPA, PDGFA | FFAR4 697/4885FFAR1 713/4885NPSR1 1464/4885 |
| US-20130289112-A1 | SALTS OF KUKOAMINE B, PREPARATION METHOD AND USE THEREOF | TLR4, BDKRB1, KLKB1 | FFAR4 2542/4885FFAR1 2461/4885NPSR1 1008/4885 |
| US-20160375135-A1 | PHENYLALKYLCARBOXYLIC ACID DELIVERY AGENTS | PGF, LIPA, PDGFA | FFAR4 697/4885FFAR1 713/4885NPSR1 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.